Richard Milne responds to PHARMAC on discounting future health benefits and costs [2]

New Zealand Medical Journal

Volumn 118, Issue 1220, 2005, Pages

  Milne, Richard ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ECONOMIC EVALUATION; GOVERNMENT; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH PROGRAM; HEALTH SERVICES RESEARCH; LETTER; MEDICAL DECISION MAKING; NEW ZEALAND; PREVENTIVE MEDICINE; PUBLIC HEALTH SERVICE; WORLD HEALTH ORGANIZATION;

EID: 27244442695     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Metcalfe S, Brougham M, Moodie P, Grocott R. PHARMAC responds to Richard Milne on discounting health benefits and costs. N Z Med J. 2005;119(1219). URL: http://www.nzma.org.nz/journal/118-1219/1600
2. Milne R. Valuing prevention: discounting health benefits and costs in New Zealand. N Z Med J. 2005;118(1214). URL: http://www.nzma.org.nz/journal/118-1214/1443/
3. Gold M, Siegel J, Russell L, Weinstein M. Cost effectiveness in health and medicine. New York, Oxford: Oxford University Press; 1996.
4. Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the Panel on Costeffectiveness in Health and Medicine. JAMA. 1996;276:1253-8.
5. Young L. Determining the discount rate for Government projects: NZ Government; 2002. Report No.: NZ Treasury Working Paper 02/21. Available online. URL: http://www.treasury.govt.nz/workingpapers/2002/twp02-21.pdf Accessed August 2005.
6. ISPOR. Pharmacoeconomic Guidelines Around The World; 2005. Available online. URL: http://www.ispor.org/PEguidelines/index.asp Accessed August 2005.
7. Bos JM, Postma MJ, Annemans L. Discounting health effects in pharmacoeconomic evaluations. PharmacoEconomics. 2005;23:639-49.